Vacmedix

A spin-out from the University of Oxford, Oxford Vacmedix, will commercialise a new technology with the potential to reduce the cost of vaccine development significantly and increase the effectiveness of vaccines in providing immunity against both infectious diseases and cancer.  The technology makes use of techniques that have already produced effective vaccines under laboratory conditions.

Advertisements

Leave a comment

February 19, 2013 · 12:31 am

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s